FL S0222

Caps out-of-pocket costs for insulin at $35 for a 30-day supply, regardless of the quantity or type prescribed

Limits cost-sharing for diabetes devices (blood glucose test strips, glucometers, continuous glucometers, lancets, lancing devices, insulin syringes) to $100 for a 30-day supply

Limits cost-sharing for diabetic ketoacidosis screening and prevention devices to $100 for a 30-day supply

Applies to health insurance policies delivered, issued, renewed, or amended on or after January 1, 2027, including group, blanket, and franchise health insurers, prepaid limited health service organizations, discount plan organizations, and health maintenance organizations

Takes effect July 1, 2026